Detalhe da pesquisa
1.
Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.
Proc Natl Acad Sci U S A
; 115(25): 6410-6415, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866855
2.
Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.
Blood
; 127(17): 2131-43, 2016 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864341
3.
Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma.
Br J Haematol
; 177(4): 557-561, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295185
4.
A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.
Ann Surg Oncol
; 22 Suppl 3: S758-65, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26350370
5.
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.
Blood
; 119(18): 4253-63, 2012 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22411871
6.
Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach.
Eur Heart J
; 34(6): 462-75, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23103659
7.
Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts.
Mol Cancer
; 9: 168, 2010 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20579391
8.
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
J Exp Clin Cancer Res
; 38(1): 446, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31676012
9.
Estrogen-mediated downregulation of CD24 in breast cancer cells.
Int J Cancer
; 123(1): 66-72, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18404683
10.
Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast.
BMC Cancer
; 8: 364, 2008 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19077243
11.
Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.
Clin Cancer Res
; 13(11): 3198-206, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17545523
12.
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA.
J Hematol Oncol
; 11(1): 112, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180865
13.
An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis.
Leuk Lymphoma
; 58(8): 1922-1930, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27919179
14.
Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project.
Sci Data
; 4: 170170, 2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29160867
15.
Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment.
BMC Cancer
; 6: 86, 2006 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16603054
16.
Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib.
Exp Hematol
; 33(5): 542-9, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15850831
17.
Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest.
Cancer Res
; 76(10): 2868-75, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013194
18.
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes.
Sci Rep
; 6: 29930, 2016 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27435027
19.
c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.
Breast Cancer Res
; 7(3): R374-84, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15987433
20.
Mechanisms of clinical resistance to small molecule tyrosine kinase inhibitors targeting oncogenic tyrosine kinases.
Am J Pharmacogenomics
; 5(2): 101-12, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15813673